Genomic Analysis of Plasmodium vivax Populations and Drug Resistance
Author Information
Author(s): Ngwana-Joseph Gabrielle C., Phelan Jody E., Manko Emilia, Dombrowski Jamille G., da Silva Santos Simone, Suarez-Mutis Martha, Vélez-Tobón Gabriel, Tobón Castaño Alberto, Machado Ricardo Luiz Dantas, Marinho Claudio R. F., Nolder Debbie, Nosten François, Sutherland Colin J., Campino Susana, Clark Taane G.
Primary Institution: London School of Hygiene and Tropical Medicine, London, UK
Hypothesis
What are the molecular drivers of chloroquine resistance in Plasmodium vivax?
Conclusion
The study identifies novel markers for resistance surveillance and highlights the evolutionary dynamics of drug resistance in Plasmodium vivax populations.
Supporting Evidence
- Selective sweeps in a locus proximal to pvmdr1 distinguish chloroquine-resistant isolates.
- An increasing prevalence of novel SNPs in the candidate resistance gene pvmrp1 was observed in Indonesian isolates.
- Genome-wide analyses revealed evidence for recent positive selection in P. vivax populations.
Takeaway
Scientists studied a lot of malaria samples to understand why some are resistant to a common medicine. They found new clues that could help track and fight this resistance.
Methodology
The study used a genome-wide approach to analyze 1534 P. vivax isolates from 29 countries, focusing on population structure, relatedness, and resistance profiling.
Potential Biases
Potential bias in sampling may affect the generalizability of the findings.
Limitations
The study may not capture all genetic diversity due to the limited number of isolates from certain regions.
Participant Demographics
Isolates were collected from 29 endemic countries, including regions in East Africa, South America, South Asia, and Southeast Asia.
Statistical Information
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website